A subcutaneous bolus of insulin (Humulin R) was injected 60 mins before running to replicate the hyperinsulinaemia/hypoglycaemia commonly observed in humans with T1D undertaking exercise. The gene discussed is INS; the disease is type 1 diabetes mellitus.